Filtering by
- All Subjects: Chemistry
- Creators: School of Molecular Sciences
- Resource Type: Text
- Status: Published
Though schizophrenia was categorized as a mental illness over 100 years ago, there is a plethora of knowledge that continues to perplex the scientific and medical community alike. This tragic mental disorder affects approximately 1% of the general population, and many of these individuals are homeless if left untreated. Each schizophrenia patient has a different set of symptoms, so all of these patients experience a variety of positive and negative symptoms. Negative symptoms are called so as they are in absence, and some examples include apathy, anhedonia, lack of motivation, reduced social drive, and reduced cognitive functioning. Positive behavior, on the other hand, is a change in behavior or thoughts such as visual or auditory hallucinations, delusions, confused thoughts, disorganized speech, and trouble concentrating. Because schizophrenia patients do not share the exact same set of symptoms, research in schizophrenia requires a tremendous amount of medical resources. Over the last few years, new studies have started in the field of schizophrenia involving proteomics, or the study of proteins and their function. This new frontier gives doctors and scientists alike a new opportunity to improve the quality of life of schizophrenia patients by providing a potential method through which patients would receive individualized treatment based on their specific symptoms.
In order to further compare porcine and human-derived enzymes, a determination of the enzyme effectiveness was done via digestion simulation. The digestion for both the human and porcine-derived enzymes consisted of three steps: oral, gastric, and intestinal. After the digestion, the absorbance for each enzyme class as well as a dilution curve of the formula used was read and recorded. Using the standard dilution curve and the absorbance values for each unknown, the formula and thus enzyme concentration that was lost through the reaction was able to be calculated.
The effectiveness of both the human and porcine enzymes, determined by the percent of formula lost, was 18.2% and 19.7%, respectively, with an error of 0.6% from the spectrophotometer, and an error of about 10% from the scale used for measuring the enzymes. This error was likely due to the small mass required of the enzymes and can be prevented in the future by performing the experiment at a larger scale.
Aboveground nitrogen content showed a maximum in 2011, decreasing until 2015, increasing again until 2017, and dropping in 2018; belowground nitrogen content showed the opposite temporal trend. Because foliar nitrogen content was assumed to be relatively constant over time, my data suggested that belowground nitrogen content increased between 2011 and 2015 and decreased between 2015 and 2017. Aboveground nitrogen content underwent fluctuations due to fluctuations in aboveground biomass. This occurred due to ‘thatching’, or events of widespread toppling of large macrophyte stands. The ratio of aboveground to belowground biomass can vary widely in the same CTW. My findings suggested that managing senesced aboveground plant material in CTWs may optimize the CTW’s ability to sequester nitrogen. Further research is needed to determine the best management strategies, as well as its possible implications.